Verified· 2 sources

OrchestratePharma GmbH

Summary

About the company

OrchestratePharma GmbH is a drug development company focused on drug repurposing (DRPx) of known molecular entities, notably fexofenadine. It is developing a topical product, FexoTopic (OP2101), for treatment of mild to moderate atopic dermatitis and pursues strategic partnerships with CROs, data-science and DRPx collaborators to accelerate development.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered3

Drug development

Drug development with repurposing of known molecules, DRPx strategies, preclinical and clinical development, and partnerships for accelerated development pathways.

FexoTopic (OP2101)

Lotion in development for the treatment of mild to moderate atopic dermatitis, as short- and long-term monotherapy with itch relief, inflammation control and skin barrier support.

Strategic partnerships

Strategic partnerships with CRO, data science, software and DRPx companies, as well as investors and partners, to accelerate development and go-to-market pathways.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

OrchestratePharma GmbH

About the company

Products & services

Looking for direct email addresses and phone numbers?

OrchestratePharma GmbH

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

OrchestratePharma GmbH in comparison

Industry comparisons are coming soon

Similar companies